1. Home
  2. NAGE vs NIE Comparison

NAGE vs NIE Comparison

Compare NAGE & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$6.37

Market Cap

766.4M

Sector

Health Care

ML Signal

HOLD

Logo Virtus Equity & Convertible Income Fund of Beneficial Interest

NIE

Virtus Equity & Convertible Income Fund of Beneficial Interest

HOLD

Current Price

$24.79

Market Cap

718.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAGE
NIE
Founded
1999
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
766.4M
718.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NAGE
NIE
Price
$6.37
$24.79
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$16.33
N/A
AVG Volume (30 Days)
748.2K
70.5K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
9.04%
EPS Growth
1093.81
N/A
EPS
0.23
N/A
Revenue
$124,709,000.00
N/A
Revenue This Year
$30.37
N/A
Revenue Next Year
$20.36
N/A
P/E Ratio
$27.76
N/A
Revenue Growth
36.04
N/A
52 Week Low
$5.16
$18.61
52 Week High
$14.69
$22.47

Technical Indicators

Market Signals
Indicator
NAGE
NIE
Relative Strength Index (RSI) 37.92 38.02
Support Level $6.40 $25.43
Resistance Level $6.77 $25.75
Average True Range (ATR) 0.22 0.27
MACD 0.01 -0.05
Stochastic Oscillator 3.77 6.00

Price Performance

Historical Comparison
NAGE
NIE

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest

Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.

Share on Social Networks: